These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Long-term follow up of rates of secondary malignancy and late relapse of two trials using radioimmunotherapy consolidation following induction chemotherapy for previously untreated indolent lymphoma. Reiss J, Link B, Ruan J, Furman R, Coleman M, Leonard J, Martin P. Leuk Lymphoma; 2015; 56(10):2870-5. PubMed ID: 25676037 [Abstract] [Full Text] [Related]
11. Myelodysplastic syndrome in a child with a history of medulloblastoma. Akyüz C, Emir S, Güler N, Tüker A, Büyükpamukçu M. Turk J Pediatr; 1998 Jul 13; 40(1):131-4. PubMed ID: 9673540 [Abstract] [Full Text] [Related]
15. Prognostic variables in bone marrow transplantation for secondary leukaemia and myelodysplastic syndromes: a survey of the working party on leukaemia. de Witte T, Hermans J, van Biezen A, Vernant J, Kolb H, Zwaan F, Vossen J, Lönnqvist B, Beelen D, Ferrant A. Bone Marrow Transplant; 1991 Jul 13; 7 Suppl 2():40. PubMed ID: 1878713 [No Abstract] [Full Text] [Related]
17. The heterogeneity of leukemia occurring after treatment for sarcoma. Varterasian M, Zalupski M, Karanes C. Am J Clin Oncol; 1997 Dec 13; 20(6):585-6. PubMed ID: 9391546 [Abstract] [Full Text] [Related]
18. Comprehensive analysis of factors impacting risks and outcomes of therapy-related myeloid neoplasms following breast cancer treatment. Sevcikova K, Zhuang Z, Garcia-Manero G, Alvarez RH, Kantarjian HM, Mego M, Albarracin C, Tang G, Strom SS, Medeiros LJ, Hortobagyi GN, Reuben JM, Khoury JD. Leukemia; 2016 Jan 13; 30(1):242-7. PubMed ID: 25975189 [No Abstract] [Full Text] [Related]